Skip to main content
Journal ArticleOPEN ACCESS

The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas

  • Tascilar M
  • Loos W
  • Seynaeve C
  • et al.
The Oncologist (2007) 12(11) 1351-1360
DOI: 10.1634/theoncologist.12-11-1351
63Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After completing this course, the reader will be able to: Describe the current role of ifosfamide in the treatment of soft tissue sarcomas in adult patients.Discuss factors that may affect ifosfamide metabolism and its therapeutic index.Explain the advantages of ifosfamide over doxorubicin in the context of new treatment combinations.Discuss strategies to improve survival outcome in patients with soft tissue sarcoma.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Cite

CITATION STYLE

APA

Tascilar, M., Loos, W. J., Seynaeve, C., Verweij, J., & Sleijfer, S. (2007). The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas. The Oncologist, 12(11), 1351–1360. https://doi.org/10.1634/theoncologist.12-11-1351

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free